Unknown

Dataset Information

0

Does successful smoking cessation reduce anxious arousal among treatment-seeking smokers?


ABSTRACT: There is limited work that has examined the effect of quitting smoking on anxious arousal, an underlying dimension of anxiety symptoms and psychopathology.Smokers (n=185, 54.1% female) enrolled in a smoking cessation treatment trial were monitored post-cessation in terms of abstinence status (biochemically verified; at Weeks 1, 2, and Month 1 post-quit) and severity of panic-relevant symptoms (self-reported; at Month 1 and 3 post-quit). Structural equation models were conducted, adjusting for participant sex, age, treatment condition, and pre-cessation nicotine dependence, presence of depressive/anxiety disorders, anxious arousal, and anxiety sensitivity.After adjusting for covariates, participants who remained abstinent for one month (n=80; 43.2%) relative to those who did not (n=105; 56.8%) demonstrated significant reductions in anxious arousal at Month 1 (?=-.26, p=.04) and Month 3 post-quit (?=-.36, p=.006); abstinence status had a non-significant effect on anxious arousal severity at Month 3 after controlling for Month 1 anxious arousal (?=-.18, p=.09).Findings align with theoretical models of smoking-anxiety interplay and suggest that smoking cessation can result in reductions in anxious arousal.

SUBMITTER: Farris SG 

PROVIDER: S-EPMC4658244 | biostudies-literature | 2015 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Does successful smoking cessation reduce anxious arousal among treatment-seeking smokers?

Farris Samantha G SG   Allan Nicholas P NP   Morales Patricia C PC   Schmidt Norman B NB   Zvolensky Michael J MJ  

Journal of anxiety disorders 20150912


<h4>Introduction</h4>There is limited work that has examined the effect of quitting smoking on anxious arousal, an underlying dimension of anxiety symptoms and psychopathology.<h4>Method</h4>Smokers (n=185, 54.1% female) enrolled in a smoking cessation treatment trial were monitored post-cessation in terms of abstinence status (biochemically verified; at Weeks 1, 2, and Month 1 post-quit) and severity of panic-relevant symptoms (self-reported; at Month 1 and 3 post-quit). Structural equation mod  ...[more]

Similar Datasets

| S-EPMC8802811 | biostudies-literature
| S-EPMC8279185 | biostudies-literature
| S-EPMC5034872 | biostudies-literature
| S-EPMC5531288 | biostudies-literature
| S-EPMC5975182 | biostudies-literature